Next generation products for targeted molecular imaging of diseases

 
Mobile_BG_alt2.jpg
 

At Fuzionaire Diagnostics, our mission is to develop new, customized molecular imaging agents for the non-invasive detection and localization of a wide variety of diseases, from specific cancers to cardiac and neurodegenerative diseases.

Our proprietary technology applies to radiochemistry the breakthrough featured in the Caltech film Element 19, which enables record-breaking, ultra-fast radiolabeling efficiency and the ability to bioconjugate an enormous range of new molecules.

From a Nobel Prize-winning lab at Caltech and the world-renowned Crump Institute for Molecular Imaging at UCLA, and with an advisory team that includes the inventor of positron emission tomography (PET) and the PET scanner, our award-winning work transforms what is possible in the diagnosis and treatment of many of the most debilitating and damaging diseases.

 

contact@fuzionairedx.com